BONTAC - Continuous innovator in the synthetic biology industry

CN / EN
Company Profile

Continuously leading the synthetic biology industry

Founded in July 2012, Bontac Bio-Engineering (Shenzhen) Co., Ltd. (hereafter referred to as BONTAC) is a high-tech enterprise integrating R&D, production and sales, with enzyme catalysis as the core biosynthetic technology. There are six major series of products in BONTAC, involving coenzymes, natural products, sugar substitutes, cosmetics, dietary supplements and medical intermediates.

As the leader of the global NMN industry, BONTAC has the first whole-enzyme catalysis technology in China. Our coenzyme products are widely used in fields such as nutrition and health, biomedicine, medical beauty, daily chemical and green agriculture.

BONTAC adheres to independent innovation, with more than 180 invention patents. BONTAC has undertaken lots of government key technology projects at provincial and municipal level. What’s more, BONTAC has established the first coenzyme engineering technology research center at the provincial level in China which also is the sole in Guangdong Province.

BONTAC will focus on its advantages of green, low-carbon and high-value-added biosynthesis technology, and build ecological relationship with academia as well as upstream/downstream partners, continuously leading the synthetic biological industry and creating a better life for human beings.

Corporate Culture

Corporate Culture

In the future, the company will continue to maintain continuous investment in R & D and innovation, use its own R & D experience and industrialization advantages, promote the application of cutting-edge scientific theories and biotechnology in the field of synthetic biology, constantly expand product boundaries, create a series of product platforms, and create a healthier and better life for human beings!

Bontac Interpretation

Practical work promotes prosperity and innovation leads to prosperity

Bontac Mission

Green biotechnology, creating a healthy and beautiful life

Bontac Vision

Continuously leading the synthetic biology industry

Bontac values

Support customers to achieve their success, creating our own value；Adhere to pragmatism and integrity, leading the way with innovation

Strive for the foundation, grow together！

Company History

Strive high and forge ahead
Bontac Bio-Engineering (Shenzhen) Co., Ltd. is willing to join hands with more customers to walk the path of high-quality service, and create a better life and a beautiful world using coenzymes together!

2012

2012

Founding of Bontac Bio-Engineering (Shenzhen) Co., Ltd

2013

2013

Obtainment of "Excellent Enterprise Award" in the China (Shenzhen) Innovation and Entrepreneurship Competition.

Support by financial funding from Shenzhen Science and Technology Innovation Program.

2014

2014

The world’s first production line for whole-enzyme catalysis was established in BONTAC, realizing the production of NMN raw materials at the kilogram even ton level.

In cooperation with Harvard Medical School, BONTAC provided NMN raw materials for the anti-aging experiments of Professor David Sinclair who then successfully published the research results in “CELL” journal. On this basis, Joint Research Center of BONTAC and Harvard Medical School was subsequently established.

2015

2015

Recognition as a high-tech enterprise in China.

Establishment of the first research institute for green biosynthesis in China.

2016

2016

BONTAC project of “Industrialization of the Core Raw Material Coenzyme” in Biocatalysis" was supported by special funds of 30 million yuan from Development and Reform Commission of Shenzhen Municipality.

2017

2017

Top 100 Biotechnology company in Guangdong province.

Construction of enzyme manufacturing base with annual output of 1,000 tons.

2018

2018

Approval to set up the first provincial coenzyme engineering technology research center in China.

Obtainment of Shenzhen Science and Technology Progress Award.

2019

2019

Sales volume exceeding 100 million yuan.

Market share of NMN raw materials exceeding 60%-70%.

2020

2020

Implement of the 3rd generation whole-enzyme catalysis technology, with production capacity exceeding 100 tons.

Serving more than 1,000 customers around the world.

2021

2021

The first to launch mass production of NMNH worldwide.

Recognition as SRDI enterprise in Shenzhen.

The top 100 innovative enterprise in China.

2022

2022

BONTAC NMN and Phosphatidylserine listed as “Guangdong Famous High-Tech Products in 2022”.

Obtainment of the key special funds of 10 million for green bio-manufacturing from Department of Science and Technology of Guangdong Province.

Recognition as the “Synthetic Biology Enterprises” in Guangming district, and movement to the Synthetic Biology Industrial Park of Guangming Science City.

BONTAC cooperation with Angel Yeast to launch the 200-ton NMN production project.

The launch of super factory project for BONTAC natural products in Fuyang, Anhui province.

Merger, acquisition and reorganization of BONTAC by Qifu Capital.

2023

2023

2023 Deloitte China Life Sciences & Healthcare Rising Star.

KPMG China's top 50 Biotech Innovation Enterprises in 2023.

Strategic cooperation with Shanghai Cell Therapy Group.

Major drafter of the group standard for NMNH: Quality Requirements and Test Methods for the Reduced Form of Nicotinamide Adenine Dinucleotide.

One drafter of the group standard for NAD: Product Requirements and Test Methods for Nicotinamide Adenine Dinucleotide.

NADH, Ginsenoside Rh2 and Stevioside RD listed as "Guangdong Famous High-Tech Products in 2023.

Health Industry Standard Innovation Award.

Health Industry Science and Technology Innovation Award.

2024

Stay tuned for the future

2024

BONTAC NMN raw materials obtain the certification of SELF GRAS by US FDA.

Excellent Brand in Synthetic Biology and Biological Manufacturing in 2024.

Received the "Annual Innovation Product Gold Award".

Jury Special Prize in IFIA Japan 2024.

Natural Ingredients Award for Innovative Technology.

......